TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA · XNYSCIK 818686fmd_03PSJXMXXNVJX0R7PADE005SZ3Industri Pengolahan · Sediaan FarmasiTemplat: Standar
Cakupan: 01 Jan 2007 hingga 30 Sep 2026, 76 periode
| Pos laporan | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total pendapatan | 21.903 | 21.853 | 18.271 | 16.887 | 16.659 | 15.878 | 14.925 | 15.846 | 16.544 | 17.258 |
| Beban pokok pendapatan | 10.250 | 11.237 | 9.975 | 9.351 | 8.933 | 8.284 | 7.952 | 8.200 | 8.481 | 8.320 |
| Laba kotor | 11.653 | 10.615 | 8.296 | 7.537 | 7.726 | 7.594 | 6.973 | 7.645 | 8.064 | 8.938 |
| Penelitian dan pengembangan | 422 | 175 | 114 | 1.010 | 997 | 967 | 98 | 953 | 998 | 1.013 |
| Beban penjualan, umum dan administrasi | 4.973 | 4.846 | 4.214 | 3.806 | 3.671 | 3.528 | 3.445 | 3.498 | 3.702 | 3.973 |
| Laba operasi | 2.154 | (17.484) | (1.637) | (443) | (3.572) | 1.716 | (2.197) | 433 | (303) | 2.157 |
| Beban bunga | 546 | 875 | 920 | 822 | 901 | 891 | 930 | 1.029 | 1.002 | 916 |
| Pendapatan (beban) nonoperasi lainnya | (1.330) | (895) | (959) | (822) | (834) | (1.058) | (966) | (1.057) | (981) | (934) |
| Laba sebelum pajak | 824 | (18.379) | (2.596) | (1.265) | (4.406) | 658 | (3.163) | (624) | (1.284) | 1.223 |
| Beban pajak penghasilan | 521 | (1.933) | (195) | (278) | (168) | 211 | (643) | (7) | 676 | (180) |
| Laba bersih dari operasi yang dilanjutkan | 303 | (16.446) | (2.401) | (987) | (4.238) | 447 | (2.520) | (617) | (1.960) | 1.403 |
| Laba bersih | 329 | (16.265) | (2.150) | (999) | (3.990) | 417 | (2.446) | (559) | (1.639) | 1.410 |
| Laba bersih yang diatribusikan kepada pemegang saham biasa | 68 | (16.525) | (2.399) | (999) | (3.990) | 417 | (2.446) | (559) | (1.639) | 1.410 |